Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Nursing role in the assessment and care of hepatic sinusoidal obstruction syndrome patients: a consensus paper by the “Gruppo Italiano Trapianto di Midollo Osseo”

  • 65 Accesses

Abstract

Purpose

Sinusoidal obstruction syndrome (SOS) is one of the most serious complications post haematopoietic stem cell transplantation (HSCT). The diagnosis of SOS is clinical, but nurses should be involved in the pre-transplant risk assessment period and play a crucial role in the early detection of signs and symptoms during and after hospitalization. The aim of this work is to achieve a consensus on nurses’ behaviour in caring for SOS.

Methods

On behalf of the Italian Group for Bone and Marrow Transplantation (GITMO), a promoter committee was established to put in place a consensus conference approach. A multidisciplinary group of GITMO together with four nurses, three haematology physicians and one patient representative acted as jury, who reviewed the reports and wrote recommendations and suggestions. Recommendations gaining 100% of consensus were considered ‘Golden Points of Care’; if a consensus was achieved by ≥ 75% of the jury’s members, those recommendations were defined as ‘Good Practices’.

Results

Eighteen papers written by nurses as first authors have been identified. Golden Points of Care and Good Practices were worked out for the following topics: nurses’ role in general, nurses’ role in pre-transplant assessment, pre-transplant risk assessment and risk stratification, baseline monitoring, suspected mild or moderate SOS, suspected severe or very severe SOS and late-onset cases.

Conclusion

SOS is relatively rare; therefore, a holistic approach to the patients’ needs considering nursing role as essential may result in better care outcomes.

This is a preview of subscription content, log in to check access.

Fig. 1

References

  1. 1.

    Carreras E, Diaz-Ricart M (2011) The role of the endothelium in the short-term complication of hematopoietic SCT. Bone Marrow Transplant 46:1495–1502

  2. 2.

    Coppell JA, Richardson PG, Soiffer R, Martin PL, Kernan NA, Chen A, Guinan E, Vogelsang G, Krishnan A, Giralt S, Revta C, Carreau NA, Iacobelli M, Carreras E, Ruutu T, Barbui T, Antin JH, Niederwieser D (2010) Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome. Biol Blood Marrow Transplant 16:157–168

  3. 3.

    McDonald GB, Hinds MS, Fisher LD, Schoch HG, Wolford JL, Banaji M, Hardin BJ, Shulman HM, Clift RA (1993) Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients. Ann Intern Med 118:255–267

  4. 4.

    Cao Z, Villa KF, Lipkin CB, Robinson SB, Nejadnik B, Dvorak CC (2017) Burden of illness associated with sinusoidal obstruction syndrome/veno-occlusive disease in patients with hematopoietic stem cell transplantation. J Med Econ 20:871–883

  5. 5.

    Svahn BM, Remberger M, Alvin O, Karlsson H, Ringdén O (2012) Increased costs after allogeneic haematopoietic SCT are associated with major complications and re-transplantation. Bone Marrow Transplant 47:706–715

  6. 6.

    Saito AM, Cutler C, Zahrieh D, Soiffer RJ, Ho VT, Alyea EP, Koreth J, Antin JH, Lee SJ (2008) Costs of allogeneic hematopoietic cell transplantation with high-dose regimens. Biol Blood Marrow Transplant 14:197–207

  7. 7.

    Majhail NS, Mothukuri JM, Brunstein CG, Weisdorf DJ (2009) Costs of hematopoietic cell transplantation: comparison of umbilical cord blood and matched related donor transplantation and the impact of posttransplant complications. Biol Blood Marrow Transplant 15:564–573

  8. 8.

    DeLeve LD, Shulman HM, McDonald GB (2002) Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease). Semin Liver Dis 22:27–42

  9. 9.

    Helmy A (2006) Review article: updates in the pathogenesis and therapy of hepatic sinusoidal obstruction syndrome. Aliment Pharmacol Ther 23:11–25

  10. 10.

    Richardson PG, Ho VT, Cutler C, Glotzbecker B, Antin JH, Soiffer R (2013) Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: novel insights to pathogenesis, current status of treatment, and future directions. Biol Blood Marrow Transplant 19:S88–S90

  11. 11.

    Carreras E, Diaz-Beya M, Rosinol L et al (2011) The incidence of veno-occlusive disease following allogeneic hematopoietic stem cell transplantation has diminished and the outcome improved over the last decade. Biol Blood Marrow Transplant 17:713–1720

  12. 12.

    Carreras ED-BM, Rosinol L et al (2012) Early complications after HSCT. In: EBMT handbook on hematopoietic stem cell transplantation. Forum Service, Genova

  13. 13.

    Mohty M, Malard F, Abecassis M, Aerts E, Alaskar AS, Aljurf M, Arat M, Bader P, Baron F, Bazarbachi A, Blaise D, Ciceri F, Corbacioglu S, Dalle JH, Dignan F, Fukuda T, Huynh A, Masszi T, Michallet M, Nagler A, NiChonghaile M, Okamoto S, Pagliuca A, Peters C, Petersen FB, Richardson PG, Ruutu T, Savani BN, Wallhult E, Yakoub-Agha I, Duarte RF, Carreras E (2016) Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation. Bone Marrow Transplant 51:906–912

  14. 14.

    Bajwa RPS, Mahadeo KM, Taragin BH et al (2017) Consensus report by pediatric acute lung injury and sepsis investigators and pediatric blood and marrow transplantation consortium joint working committees: supportive care guidelines for management of veno-occlusive disease in children and adolescents, part 1: focus on investigations, prophylaxis, and specific treatment. Biol Blood Marrow Transplant 23:1817–1825

  15. 15.

    Mohty M, Malard F, Abecassis M, Aerts E, Alaskar AS, Aljurf M, Arat M, Bader P, Baron F, Bazarbachi A, Blaise D, Ciceri F, Corbacioglu S, Dalle JH, Duarte RF, Fukuda T, Huynh A, Masszi T, Michallet M, Nagler A, NiChonghaile M, Pagluica T, Peters C, Petersen FB, Richardson PG, Ruutu T, Savani BN, Wallhult E, Yakoub-Agha I, Carreras E (2015) Sinusoidal obstruction syndrome/veno-occlusive disease: current situation and perspectives-a position statement from the European Society for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant 50:781–789

  16. 16.

    McDonald GB, Sharma P, Matthews DE et al (1984) Venocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors. Hepatology 4:116–122

  17. 17.

    Jones RJ, Lee KS, Beschorner WE et al (1987) Venoocclusive disease of the liver following bone marrow transplantation. Transplantation 44:778–783

  18. 18.

    Corbacioglu S, Cesaro S, Faraci M et al (2012) Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial. Lancet 379:1301–1309

  19. 19.

    Barker CC, Butzner JD, Anderson RA et al (2003) Incidence, survival and risk factors for the development of veno-occlusive disease in pediatric hematopoietic stem cell transplant recipients. Bone Marrow Transplant 32:79–87

  20. 20.

    Cesaro S, Pillon M, Talenti E, Toffolutti T, Calore E, Tridello G, Strugo L, Destro R, Gazzola MV, Varotto S, Errigo G, Carli M, Zanesco L, Messina C (2005) A prospective survey on incidence, risk factors and therapy of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation. Haematologica 90:1396–1404

  21. 21.

    Corbacioglu S, Carreras E, Ansari M, Balduzzi A, Cesaro S, Dalle JH, Dignan F, Gibson B, Guengoer T, Gruhn B, Lankester A, Locatelli F, Pagliuca A, Peters C, Richardson PG, Schulz AS, Sedlacek P, Stein J, Sykora KW, Toporski J, Trigoso E, Vetteranta K, Wachowiak J, Wallhult E, Wynn R, Yaniv I, Yesilipek A, Mohty M, Bader P (2018) Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in pediatric patients: a new classification from the European Society for Blood and Marrow Transplantation. Bone Marrow Transplant 53:138–145

  22. 22.

    Carreras E (2015) How I manage sinusoidal obstruction syndrome after haematopoietic cell transplantation. Br J Haematol 168:481–491

  23. 23.

    Lamb BW, Brown KF, Nagpal K, Vincent C, Green JS, Sevdalis N (2011) Quality of care management decisions by multidisciplinary cancer teams: a systematic review. Ann Surg Oncol 18:2116–2125

  24. 24.

    Pillay B, Wootten AC, Crowe H, Corcoran N, Tran B, Bowden P, Crowe J, Costello AJ (2016) The impact of multidisciplinary team meetings on patient assessment, management and outcomes in oncology settings: a systematic review of the literature. Cancer Treat Rev 42:56–72

  25. 25.

    Taylor C, Munro AJ, Glynne-Jones R et al (2010) Multidisciplinary team working in cancer: what is the evidence? BMJ 340:c951

  26. 26.

    Becze E (2012) Veno-occlusive disease is the most common hepatic complication in stem cell transplants. ONS Connect 27:16–17

  27. 27.

    Sosa EC (2012) Veno-occlusive disease in hematopoietic stem cell transplantation recipients. Clin J Oncol Nurs 16:507–513

  28. 28.

    Oestreicher P (2008) Recognize hepatic sinusoidal obstruction syndrome in patients with cancer. ONS Connect 23:22–23

  29. 29.

    Krimmel T, Williams LA (2008) Hepatic sinusoidal obstruction syndrome following hematopoietic stem cell transplantation. Oncol Nurs Forum 35:37–39

  30. 30.

    Wallhult E, Kenyon M, Liptrott S, Mank A, Ní Chonghaile M, Babic A, Bijkerk J, Bompoint C, Corbacioglu S, de Weijer R, Fink C, Marktel S, Soni V, Sprenger S, Arjona ET, Mohty M (2017) Management of veno-occlusive disease: the multidisciplinary approach to care. Eur J Haematol 98:322–329

  31. 31.

    Botti S, Orlando L, Gargiulo G et al (2016) Veno-occlusive disease nurse management: development of a dynamic monitoring tool by the GITMO nursing group. Ecancermedicalscience 10:661

  32. 32.

    Eisenberg S (2008) Hepatic sinusoidal obstruction syndrome in patients undergoing hematopoietic stem cell transplant. Oncol Nurs Forum 35:385–397

  33. 33.

    Poliquin CM (1990) Post-bone marrow transplant patient management. Yale J Biol Med 63:495–502

  34. 34.

    Buchesel PC, Kelleher J (1989) Bone marrow transplantation. Nurs Clin North Am 24:907–938

  35. 35.

    Grandt NC (1989) Hepatic veno-occlusive disease following bone marrow transplantation. Oncol Nurs Forum 16:813–817

  36. 36.

    Ford R, McClain K, Cunningham BA (1983) Veno-occlusive disease following marrow transplantation. Nurs Clin North Am 18:563–568

  37. 37.

    Carreras E, Bertz H, Arcese W et al (1998) Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation: a prospective cohort study of the European Group for Blood and Marrow Transplantation. European Group for Blood and Marrow Transplantation Chronic Leukemia Working Party. Blood 92:3599–3604

  38. 38.

    Bearman SI, Anderson GL, Mori M, Hinds MS, Shulman HM, McDonald G (1993) Venoocclusive disease of the liver: development of a model for predicting fatal outcome after marrow transplantation. J Clin Oncol 11:1729–1736

  39. 39.

    Dalle JH, Giralt SA (2016) Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: risk factors and stratification, prophylaxis, and treatment. Biol Blood Marrow Transplant 22:400–409

  40. 40.

    Freedman S, Shivnan J, Tilles J et al (1990) Bone marrow transplantation: overview and nursing implications. Crit Care Nurs Q 13(2):51–62

  41. 41.

    Wikle T, Coyle K, Shapiro D (1990) Bone marrow transplant. Today and tomorrow. Am J Nurs 90(5):48–56

  42. 42.

    Richardson PG, Riches ML, Kernan NA, Brochstein JA, Mineishi S, Termuhlen AM, Arai S, Grupp SA, Guinan EC, Martin PL, Steinbach G, Krishnan A, Nemecek ER, Giralt S, Rodriguez T, Duerst R, Doyle J, Antin JH, Smith A, Lehmann L, Champlin R, Gillio A, Bajwa R, D’Agostino RB Sr, Massaro J, Warren D, Miloslavsky M, Hume RL, Iacobelli M, Nejadnik B, Hannah AL, Soiffer RJ (2016) Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure. Blood 127:1656–1665

  43. 43.

    Saria MG, Gosselin-Acomb TK (2007) Hematopoietic stem cell transplantation: implications for critical care nurses. Clin J Oncol Nurs 11(1):53–63

  44. 44.

    Piccin A, Sartori MT, Bisogno G, van Schilfgaarde M, Saggiorato G, Pierro AMD, Corvetta D, Marcheselli L, Andrea M, Gastl G, Cesaro S (2017) New insights into sinusoidal obstruction syndrome. Intern Med J 47:1173–1183

  45. 45.

    Lazzari L, Marra P, Greco R, Giglio F, Clerici D, Venturini E, Paesano P, Albanese S, Serio F, Ciceri F, Peccatori J (2019) Ultrasound elastography techniques for diagnosis and follow up of hepatic veno-occlusive disease. Bone Marrow Transplant 54:1145–1147

  46. 46.

    Ni Chonghaile M, Wolownik K (2018) Identification and management: sinusoidal obstruction syndrome/veno-occlusive disease related to hematopoietic stem cell transplantation. Clin J Oncol Nurs 22:E7–E17

  47. 47.

    Dignan FL, Wynn RF, Hadzic N et al (2013) BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation. Br J Haematol 163:444–457

  48. 48.

    Yakushijin K, Atsuta Y, Doki N et al (2016) Sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation: incidence, risk factors and outcomes. Bone Marrow Transplant 51:403–409

Download references

Author information

Correspondence to Stefano Botti.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Botti, S., Agreiter, I., Orlando, L. et al. Nursing role in the assessment and care of hepatic sinusoidal obstruction syndrome patients: a consensus paper by the “Gruppo Italiano Trapianto di Midollo Osseo”. Support Care Cancer (2020). https://doi.org/10.1007/s00520-020-05353-9

Download citation

Keywords

  • Sinusoidal obstruction syndrome
  • Veno-occlusive disease
  • Endothelial complications
  • Multi-organ failure
  • Stem cell transplantation
  • Nurse management